Belmonti, Simone
 Distribuzione geografica
Continente #
NA - Nord America 208
EU - Europa 128
AS - Asia 34
AF - Africa 8
Totale 378
Nazione #
US - Stati Uniti d'America 208
SE - Svezia 42
IT - Italia 36
CN - Cina 20
DE - Germania 12
IE - Irlanda 10
IN - India 9
CM - Camerun 8
FR - Francia 7
GB - Regno Unito 5
FI - Finlandia 4
BE - Belgio 3
PL - Polonia 3
UA - Ucraina 3
HK - Hong Kong 2
BY - Bielorussia 1
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 378
Città #
Chandler 48
Ann Arbor 19
New York 12
Ashburn 11
Cattolica 11
Dublin 10
Jacksonville 10
Redwood City 8
San Mateo 8
Nanjing 6
Woodbridge 6
Houston 4
Lancaster 4
Milan 4
Rome 4
Boston 3
Brussels 3
Kraków 3
Princeton 3
Wilmington 3
Auburn Hills 2
Beijing 2
Boardman 2
Cambridge 2
Ciampino 2
Dearborn 2
Fairfield 2
Hong Kong 2
Lawrence 2
Shenyang 2
Tianjin 2
Amsterdam 1
Andover 1
Chongqing 1
Dallas 1
Frankfurt am Main 1
Guangzhou 1
Harbin 1
Hebei 1
Hefei 1
Jiaxing 1
Jinan 1
Mountain View 1
Nanchang 1
Nizhniy Novgorod 1
Norwalk 1
Pomezia 1
Pune 1
Seattle 1
Simi Valley 1
Tokyo 1
Velletri 1
Vitebsk 1
Totale 224
Nome #
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 89
Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study 88
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 82
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 77
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy 52
Totale 388
Categoria #
all - tutte 1.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.281


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 14 0 1 3 12 6 4 0 0 0 18 4
2020/202142 16 2 0 2 4 6 5 2 2 0 2 1
2021/202256 2 1 1 7 3 2 2 9 4 4 9 12
2022/2023116 21 18 7 18 7 11 1 13 17 1 2 0
2023/202451 3 18 6 7 1 14 2 0 0 0 0 0
Totale 388